Paris, February 2, 2026. Positive results from the LEAP2MONO phase 3 study (clinical study identifier: NCT05222906) demonstrated that venglustat met...
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 03/Feb 16:59
SNY's phase III LEAP2MONO study meets all primary endpoints, with venglustat improving neurological symptoms in type 3 Gaucher disease patients.
Paris, February 2, 2026. Positive results from the LEAP2MONO phase 3 study (clinical study identifier: NCT05222906) demonstrated that venglustat met...
Alliance Foundation Trials, LLC (AFT) today announced the publication of the pivotal phase III PATINA study (AFT-38) in the New England Journal of...
Alliance Foundation Trials, LLC (AFT) today announced the publication of the pivotal phase III PATINA study (AFT-38) in the New England Journal of...
Novo Nordisk reports that CagriSema beats semaglutide at HbA1c reduction and weight loss in a 68-week phase III diabetes study, with no weight-loss...
New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer (NSCLC) progresses after first-line...
New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer (NSCLC) progresses after first-line...
A new study from Chalmers University of Technology in Sweden, along with Oslo University Hospital in Norway, may have discovered a way to detect...
A new study from Chalmers University of Technology in Sweden, along with Oslo University Hospital in Norway, may have discovered a way to detect...
Following a Mediterranean diet is associated with a lower risk of all types of stroke among women, according to a study published...
For a long time, people with inflammatory bowel disease (IBD) have said that stress makes their symptoms worse. Doctors have noticed this too, but...